NCT00225160View on ClinicalTrials.gov

ALCAR Prophylaxis Study

PHASE2UnknownINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

November 30, 2003

Conditions

HIV InfectionsDistal Symmetric Polyneuropathy

Interventions

DRUG

acetyl L-carnitine

Trial Locations (1)

NW3 2QG

Royal Free Hospital, London

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Sigma-Tau Research, Inc.

INDUSTRY

lead

Royal Free Hampstead NHS Trust

OTHER